| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 |
# |
Score |
Template |
Links and tools | %id | First |
MIERYTLPEMGKIWTDTYKLQTWLDVEIAVCEAQAELGYIPQAAVDEIKAKAKFDPQRVLEIEAEVRHDVIAFLTNVNEYVGDAGRYIHLGLTSSDVLDTALALQLVASLDLILEQLEKLIQAIRYQAQQHRYTVMVGRSHGIHAEPITFGFKLAGWLAEVLRNRDRLVRVAQSIAVGKISGAVGTYANIDPKVEAIACQKLGLEPDTASTQVISRDRHAEYVQQLALLAASLERFAVEIRNLQRTDVLEVEEYFSKGQKGSSAMPHKRNPIRSERLTGMARLVRGHAVAALENVALWHERDISHSSVERVAFPDCCILTHFMLKETTDLVKNLLVYPENMKRNMNVYGGVIFSQKVLLALVEKGMNREDAYRVVQGSAHQAWNTEGGNFEELVRADAQVTALLSAEEIDQCFDPQQHLTNLAEIYSRLDI | Last |
1 | -128.000 | [F] COG0015 Adenylosuccinate lyase |
ali |
100 | 1 | MIERYTLPEMGKIWTDTYKLQTWLDVEIAVCEAQAELGYIPQAAVDEIKAKAKFDPQRVLEIEAEVRHDVIAFLTNVNEYVGDAGRYIHLGLTSSDVLDTALALQLVASLDLILEQLEKLIQAIRYQAQQHRYTVMVGRSHGIHAEPITFGFKLAGWLAEVLRNRDRLVRVAQSIAVGKISGAVGTYANIDPKVEAIACQKLGLEPDTASTQVISRDRHAEYVQQLALLAASLERFAVEIRNLQRTDVLEVEEYFSKGQKGSSAMPHKRNPIRSERLTGMARLVRGHAVAALENVALWHERDISHSSVERVAFPDCCILTHFMLKETTDLVKNLLVYPENMKRNMNVYGGVIFSQKVLLALVEKGMNREDAYRVVQGSAHQAWNTEGGNFEELVRADAQVTALLSAEEIDQCFDPQQHLTNLAEIYSRLDI |
431 |
2 | -111.000 | [F] KOG2700 Adenylosuccinate lyase |
ali follow.. |
25 | 11 | LTARYASAEMSHLFSREMRINTWRQLWLNLAIAEKQLGLITDEAIEQLKAHVKPEFEIAAKEEKRQRHDVMAHIYTYGLAAPAASGIIHLGATSCFVTDNADLIFLRSAMDLLIPKLVNVINRLSQWSLRYKDIPTLGFTHYQPAQLTTVGKRATLWIQELLWDLRNFVRARNDIGFRGVKGTTGTQASFLALFEGDHAKVEELDVYPVTGQTYDRKIDIDVLQPLASFGATAHKIATDIRLLANLK--EVEEPFEAGQIGSSAMAYKRNPMRCERICSQARYIMNLIPNALNTASQWFERTLDDSSNRRSLLPEAFLFTDSVLKILLNVISGMVIYPKVIQKHIRAELPFMATENIIMAMTKHGASRHECHEQIRVLSHQAGRVGDNDLIERIKNTPYFA--PIYDELDSLLDASTFVGRAPEQTESF.. |
457 |
3 | -91.400 | [E] KOG1316 Argininosuccinate lyase |
ali follow.. |
18 | 23 | ALHSL----NNSLPYDSRLYADDLDASKAYAEALHRAGLINSAEADKLVKNLELLRFDWIEGTLPGDEDVHTVNERLVEITGELGQRLHTGRSRNDQVVTDMKLWLRKAIRETLGRLSGIIETATRQAELHLGVLMPGYTHLQRAQTVQFSHWLLSHAGALAGNPLGIDRLWLAERLGFSGVTANSM-----------------------HAVGDRDFVVDFIYCCSMVSLHLSRLAEDLIIYSTKEFDFIKLA-DGFSSGSSLMPQKRNPDSLELIRGMAGVITANLTGIMMTIKGTPSTYNKDLQYDKQFCFQSFDKLSQVLEVTDGVLQTIQVKQESMEAALS---TDMLATDWAYYLVKKGVPFRQAHHIIGRVVSEAEK-RGVDITDLPLGDLQKFSPLFGSDIVAVADYSNNVGTASSSIVEQ.. |
430 |
4 | -90.800 | [E] COG0165 Argininosuccinate lyase |
ali follow.. |
20 | 8 | ..DRFEGT-NASIGFDIELIEYDLDGSIAHGKMLAKTGIISPGEAEQLVQGLEQIRQEYRAGNGVDQEDVHFAVERLTELVGDVGKKLHTARSRNDQVGTDVRLYLRAQIDDIRQRLRDFQAVLLQLAETNVETLIPGYTHLQRAQPVSLAHHLLAYFQMAQRDWQRLGEIRARTNVSPLGSGALAGTTFPID-RHYSAELLGFAGVYANDGVSDRDFAIEFLNAASLIMVHLSRLSEEMILWASQEFSFISLT-DSCATGSSIMPQKKNPDVPELIRGKAGRVMGHLQGMLVLMKGLPLAYNKDLQEDKEALFDAVKTVQVSLEAMTILLDEGIVFRQERLAEAVAE-DFSNATDVADYLAAKGVPFREAYNLVGKVVKTSLA-AGKLLKDLTLAEWQALHPAFEEDIYQAITPQQVVGTGFEQVKMA.. |
450 |
5 | -76.700 | [C] COG0114 Fumarase |
ali follow.. |
16 | 83 | ...GIVKQAAARANMALAGLDPKVGDAIIAAAQEVIDGKLTEHFPLVVWQTGSGTQSNMNANEVISNRAIEMLGGEMGTKKPHPNDHVNMSQSSNDTYPTAMHIACEEIVHHLLPALKHLHTALEAKVKQFEKIIKIGRTHTQDATPLTLGQEFSGYAAQVASAIANIELTLPALSKLAQGTAVGTGLNAPVGFAEKVAEEIS-TAPNKFEALASHDSMVFSHGAINAAAAALFKIANDIRFLGSGPRAGLGELSPENEPGSSIMPGKVNPTQSEALTQVCAHIFGNNAALSFAGSQGHELNVYNPMMAYNFLQSVQLLGDAAVSFTDNCVVGIEAREDNIRKGVENSLMLVTA-----------LNGKLGYDICAKIAKTAHK-NGTTLREEAVGG----GYLTNEEFDQYVRPENMIG........... |
495 |
6 | -67.700 | [C] KOG1317 Fumarase |
ali follow.. |
17 | 18 | .......................................VPADKYYGAQTMRSQINFPIGGATEPAMGILKKAAAEVNKEFGLDSKVSEAISKAADDVISGKLYDDHFPLVIWQTGSGTQSNMNVNESEEFKDIIKIGRTHTMDAVPLTLGQEFSGYAQQLAYAQERIDACLPRVYELALGGTAVGTGGFAEKCAAKIAELTSLPFVTAPEALAARDAMVEVHGVLNTIAVSLMKIANDIRFLGSGPRCGLGELLPENEPGSSIMPGKVNPTQCESLTMLSAQVMGNQVAVTIGGSNHFELNVFKPLIVSNVLRSIRLLSDGSRTFTANCVNGIQANRENIAKIMNESLMLVTA-----------LNPHIGYDKAAKIAKTAHK-NGTTLKEEAINL----GYLTEQQFNDWVRPEQMLGP.......... |
395 |
7 | -51.900 | [E] COG1027 Aspartate ammonia-lyase |
ali follow.. |
14 | 39 | ..........SKISDVPEFVRGMVMVKKAAAMANKELHTIPRKIADIIIQACDEVLDKMNTNEVLANIGLELMGHQGEYQYLNPNDHLNKCQSTNDAYPTGFRIAVYASILKLIDAINQLGEGFGRKSKEFEKILKMGRTQLQDAVPMTLGQEFRAFQVLLNEETKNLQRTAELLLEVNLGATANTPEGYSQLAVQKLAEISGLACVPAEDATSDCGAYVMVHSALKRLAVKMSKICNDLRLLSSGPRTGLNEILPELQAGSSIMPAKVNPVIPEVVNQVCFKVIGNDTCITMAAEAGQLQLNLMEPVIGQAMFESIHILTNACYNLLECINGITANKEVCERYVF--NSIGIVTYLNPFIGHNGDIVGKICAETGKNVREVVLERGL---------------LTEAELDDIFSVENLMH........... |
464 |
8 | -4.820 | [D] COG4477 Negative regulator of septation ring formation |
ali follow.. |
5 | 106 | .....ARESVADSEAQIELMEGDVEGIRQGVAQLVEQEKRNSNKIQESLDLYDNLRSDIADNADLYGTVITELEKHLANIETEFSQFVTLNSTGDPIEAAEVLETAEEHTIALRAITEQI-KRLEELQEASDKFVAEEYILPDNVNIKE--------MDDLHDHLVESSSLLEQFELDRVEAELGLIQEKVEELYAIFEREYSARRNVEKRSSVLKEYIEHIRANNKNLLLEIDHVTQAYIL-YQEHLESLDSDVDEGNIQAKTMPYSILSRRVNSVVNALEDIEKNQIKISDTLTGLRDEERAAQEIEKCNLPDLFFTTGDRVQNLFKELGRVRINIDTINHLVEATTNLTDHAVLAEQLIQYANRYKAANEQVAQGISRALQENSRDYDGSFDEISKTLELVEPGAASRISG................. |
564 |
9 | -4.170 | [T] KOG2607 CDK5 activator-binding protein |
ali follow.. |
7 | 70 | VFGTYGSQRMKD---------------QEISRLYEKNATYLAETAQIFVRNVNYEIPGVRKQMARLEQQADETQKRLNKPESQILADHSALLEQLGVKGDNLHAEFVQVLSGLPELYDKSLVGIANIQPGNKQVLPILNHLVEFGNTTVYQYIHKEAPLAVEEPPIRLNLSEGNASKDDNAVAEIDFGTDDNGGTSSTVSAEIIDYGDFGSGDLPESDGGNIDWGIESAPTDAVEINFDIPVEEYGIVVEGTGMDGGTAKGDQAYTLLDSPNYRDRFLDEIYELESFLRMRIYELKQLESSSDIMFSLMDNIATHDGESIWKILVSVEKIIQQTS--DKQTQHLFQLKHSPKYANMLATKLQQMTKAVEKLRATREALKQLTIELREQPVLEELIAQTRTLQSHIEKDISKRYK-----NRVVNLMGGVN. |
495 |
10 | -4.060 | [DZ] KOG4302 Microtubule-associated protein essential for anaphase spindle elongation |
ali follow.. |
9 | 25 | .............................LQKIWVEIGETETEMLMELERECLQIYQRKVDEAANSKAKLHQSVASIEAEVASLMAALGVLNINSPIKLDKGSKSLKEKLAAVTPLVEELRIQKEERMKQ---------------------------FSDIKAQIEKISGEISGYSDHLNKAMNISLTLEEQDLTLRNLNEYQTHLRTLQKEKSDR------LNKVLGYVNEVHALCGVLGVDFSQTVSAVHPSLHRTDQEQSTNISDSTLEGLEHMIQKLKTERKSRFQKLKDV----------------------------VASLFELWNLMDTPQEDRTKFGKVTYVVRSSEANI-----------TEPGILSTETIEQVSTEVDSLSKLKASRMKELVMKRRSELEDLCR................. |
340 |